| Product Code: ETC13326044 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Europe Immunotherapy Drugs Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Europe Immunotherapy Drugs Market Overview |
3.1 Europe Regional Macro Economic Indicators |
3.2 Europe Immunotherapy Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Europe Immunotherapy Drugs Market - Industry Life Cycle |
3.4 Europe Immunotherapy Drugs Market - Porter's Five Forces |
3.5 Europe Immunotherapy Drugs Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Europe Immunotherapy Drugs Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.7 Europe Immunotherapy Drugs Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.8 Europe Immunotherapy Drugs Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Europe Immunotherapy Drugs Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.10 Europe Immunotherapy Drugs Market Revenues & Volume Share, By Sales Channel, 2021 & 2031F |
4 Europe Immunotherapy Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Europe Immunotherapy Drugs Market Trends |
6 Europe Immunotherapy Drugs Market, 2021 - 2031 |
6.1 Europe Immunotherapy Drugs Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Europe Immunotherapy Drugs Market, Revenues & Volume, By Checkpoint Inhibitors, 2021 - 2031 |
6.1.3 Europe Immunotherapy Drugs Market, Revenues & Volume, By Monoclonal Antibodies, 2021 - 2031 |
6.1.4 Europe Immunotherapy Drugs Market, Revenues & Volume, By Cancer Vaccines, 2021 - 2031 |
6.1.5 Europe Immunotherapy Drugs Market, Revenues & Volume, By Cytokines, 2020 - 2028 |
6.1.6 Europe Immunotherapy Drugs Market, Revenues & Volume, By Adoptive T-Cell Therapy, 2020 - 2028 |
6.2 Europe Immunotherapy Drugs Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Europe Immunotherapy Drugs Market, Revenues & Volume, By Lung Cancer, 2021 - 2031 |
6.2.3 Europe Immunotherapy Drugs Market, Revenues & Volume, By Breast Cancer, 2021 - 2031 |
6.2.4 Europe Immunotherapy Drugs Market, Revenues & Volume, By Melanoma, 2021 - 2031 |
6.2.5 Europe Immunotherapy Drugs Market, Revenues & Volume, By Leukemia, 2021 - 2031 |
6.2.6 Europe Immunotherapy Drugs Market, Revenues & Volume, By Multiple Myeloma, 2020 - 2028 |
6.3 Europe Immunotherapy Drugs Market, Revenues & Volume, By End User, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Europe Immunotherapy Drugs Market, Revenues & Volume, By Oncology Centers, 2021 - 2031 |
6.3.3 Europe Immunotherapy Drugs Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.3.4 Europe Immunotherapy Drugs Market, Revenues & Volume, By Specialty Clinics, 2021 - 2031 |
6.3.5 Europe Immunotherapy Drugs Market, Revenues & Volume, By Research Institutions, 2021 - 2031 |
6.3.6 Europe Immunotherapy Drugs Market, Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031 |
6.4 Europe Immunotherapy Drugs Market, Revenues & Volume, By Mechanism of Action, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Europe Immunotherapy Drugs Market, Revenues & Volume, By PD-1/PD-L1 Blocking, 2021 - 2031 |
6.4.3 Europe Immunotherapy Drugs Market, Revenues & Volume, By Immune System Activation, 2021 - 2031 |
6.4.4 Europe Immunotherapy Drugs Market, Revenues & Volume, By Tumor Cell Recognition, 2020 - 2028 |
6.4.5 Europe Immunotherapy Drugs Market, Revenues & Volume, By Signal Pathway Modulation, 2020 - 2028 |
6.4.6 Europe Immunotherapy Drugs Market, Revenues & Volume, By CAR-T Cell Therapy, 2020 - 2028 |
6.5 Europe Immunotherapy Drugs Market, Revenues & Volume, By Sales Channel, 2020 - 2028 |
6.5.1 Overview & Analysis |
6.5.2 Europe Immunotherapy Drugs Market, Revenues & Volume, By Direct Sales, 2020 - 2028 |
6.5.3 Europe Immunotherapy Drugs Market, Revenues & Volume, By Online Pharmacies, 2020 - 2028 |
6.5.4 Europe Immunotherapy Drugs Market, Revenues & Volume, By Wholesale Suppliers, 2020 - 2028 |
6.5.5 Europe Immunotherapy Drugs Market, Revenues & Volume, By Government Procurement, 2020 - 2028 |
6.5.6 Europe Immunotherapy Drugs Market, Revenues & Volume, By Hospital Contracts, 2020 - 2028 |
7 Europe Immunotherapy Drugs Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Europe Immunotherapy Drugs Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.2.1 United Kingdom (UK) Immunotherapy Drugs Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.2.2 Germany Immunotherapy Drugs Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.2.3 France Immunotherapy Drugs Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.2.4 Poland Immunotherapy Drugs Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.2.5 Spain Immunotherapy Drugs Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.2.6 Rest of Europe Immunotherapy Drugs Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.3 Europe Immunotherapy Drugs Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
7.3.1 United Kingdom (UK) Immunotherapy Drugs Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
7.3.2 Germany Immunotherapy Drugs Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
7.3.3 France Immunotherapy Drugs Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
7.3.4 Poland Immunotherapy Drugs Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
7.3.5 Spain Immunotherapy Drugs Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
7.3.6 Rest of Europe Immunotherapy Drugs Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
7.4 Europe Immunotherapy Drugs Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.1 United Kingdom (UK) Immunotherapy Drugs Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.2 Germany Immunotherapy Drugs Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.3 France Immunotherapy Drugs Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.4 Poland Immunotherapy Drugs Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.5 Spain Immunotherapy Drugs Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.6 Rest of Europe Immunotherapy Drugs Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5 Europe Immunotherapy Drugs Market, Revenues & Volume, By Mechanism of Action, 2021 - 2031 |
7.5.1 United Kingdom (UK) Immunotherapy Drugs Market, Revenues & Volume, By Mechanism of Action, 2021 - 2031 |
7.5.2 Germany Immunotherapy Drugs Market, Revenues & Volume, By Mechanism of Action, 2021 - 2031 |
7.5.3 France Immunotherapy Drugs Market, Revenues & Volume, By Mechanism of Action, 2021 - 2031 |
7.5.4 Poland Immunotherapy Drugs Market, Revenues & Volume, By Mechanism of Action, 2021 - 2031 |
7.5.5 Spain Immunotherapy Drugs Market, Revenues & Volume, By Mechanism of Action, 2021 - 2031 |
7.5.6 Rest of Europe Immunotherapy Drugs Market, Revenues & Volume, By Mechanism of Action, 2021 - 2031 |
7.6 Europe Immunotherapy Drugs Market, Revenues & Volume, By Sales Channel, 2021 - 2031 |
7.6.1 United Kingdom (UK) Immunotherapy Drugs Market, Revenues & Volume, By Sales Channel, 2021 - 2031 |
7.6.2 Germany Immunotherapy Drugs Market, Revenues & Volume, By Sales Channel, 2021 - 2031 |
7.6.3 France Immunotherapy Drugs Market, Revenues & Volume, By Sales Channel, 2021 - 2031 |
7.6.4 Poland Immunotherapy Drugs Market, Revenues & Volume, By Sales Channel, 2021 - 2031 |
7.6.5 Spain Immunotherapy Drugs Market, Revenues & Volume, By Sales Channel, 2021 - 2031 |
7.6.6 Rest of Europe Immunotherapy Drugs Market, Revenues & Volume, By Sales Channel, 2021 - 2031 |
8 Europe Immunotherapy Drugs Market Key Performance Indicators |
9 Europe Immunotherapy Drugs Market - Export/Import By Countries Assessment |
10 Europe Immunotherapy Drugs Market - Opportunity Assessment |
10.1 Europe Immunotherapy Drugs Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Europe Immunotherapy Drugs Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
10.3 Europe Immunotherapy Drugs Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
10.4 Europe Immunotherapy Drugs Market Opportunity Assessment, By End User, 2021 & 2031F |
10.5 Europe Immunotherapy Drugs Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
10.6 Europe Immunotherapy Drugs Market Opportunity Assessment, By Sales Channel, 2021 & 2031F |
11 Europe Immunotherapy Drugs Market - Competitive Landscape |
11.1 Europe Immunotherapy Drugs Market Revenue Share, By Companies, 2022 |
11.2 Europe Immunotherapy Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here